Overview
Dr. Camarena is interested in utilizing novel technology for the advancement of surgical care in trauma and critically ill patients. Dr. Camarena is currently working on targeted therapeutic delivery utilizing stereo-complexed hydrogel microparticles to mediate inflammation and promote tissue regeneration in the setting of traumatic injury. He has additional interest in studying the mechanisms and potential targets for treatment in endotheliopathy in sepsis. He received his B.S. in Neuroscience from the University of Southern California (2013) and M.D. from the University of Chicago Pritzker School of Medicine (2021). He is currently completing his General Surgery residency at Duke and plans to specialize in Trauma and Critical Care.
Recent Scholarly Works
SegmentAnyMuscle: A universal muscle segmentation model across different locations in MRI.
Journal article Comput Biol Med · October 15, 2026 Muscle mass and muscle quality, characterized by intramuscular adiposity and fiber composition, are clinically established biomarkers significantly associated with obesity, sarcopenia, frailty and cardiometabolic disorders. Current muscle quantification ef ... Full text Link to item CiteThiol-yne Click Polymer Platform for Protecting Steerable Neuroendoscope Tools
Journal article Advanced Materials Technologies · January 1, 2026 Neurosurgical interventions rely increasingly on minimally invasive (MI) approaches, yet most MI surgical tools are rigid and have limited dexterity. Tendon-actuated continuum robots are an emerging strategy employing a notched body to afford curvilinear m ... Full text CiteThe importance of diversity within surgical education.
Journal article Curr Probl Surg · September 2025 Full text Link to item CiteRecent Grants
CD154 mediated local immune modulation in rib fracture healing in the elderly: A targeted approach
ResearchPI-Fellow · Awarded by American College of Surgeons · 2024 - 2026View All Grants